263 related articles for article (PubMed ID: 24510719)
21. Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D.
Morales JF; Montoto SS; Fagiolino P; Ruiz ME
Mini Rev Med Chem; 2017; 17(3):247-257. PubMed ID: 27739359
[TBL] [Abstract][Full Text] [Related]
22. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics.
Ronaldson PT; Davis TP
Expert Opin Drug Deliv; 2024; 21(1):71-89. PubMed ID: 38217410
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
24. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
25. Patented in vitro blood-brain barrier models in CNS drug discovery.
Tóth A; Veszelka S; Nakagawa S; Niwa M; Deli MA
Recent Pat CNS Drug Discov; 2011 May; 6(2):107-18. PubMed ID: 21585327
[TBL] [Abstract][Full Text] [Related]
26. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
27. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
Ohtsuki S
Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
[TBL] [Abstract][Full Text] [Related]
28. Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.
Kibathi LW; Bae S; Penzak SR; Kumar P
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):619-635. PubMed ID: 29858835
[TBL] [Abstract][Full Text] [Related]
29. A physiologically based modeling strategy during preclinical CNS drug development.
Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
Mol Pharm; 2014 Mar; 11(3):836-48. PubMed ID: 24446829
[TBL] [Abstract][Full Text] [Related]
30. Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo.
Feng MR
Curr Drug Metab; 2002 Dec; 3(6):647-57. PubMed ID: 12369891
[TBL] [Abstract][Full Text] [Related]
31. Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome.
Chaturvedi S; Rashid M; Malik MY; Agarwal A; Singh SK; Gayen JR; Wahajuddin M
Drug Discov Today; 2019 May; 24(5):1166-1175. PubMed ID: 30898661
[TBL] [Abstract][Full Text] [Related]
32. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
33. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
34. Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery.
Aday S; Cecchelli R; Hallier-Vanuxeem D; Dehouck MP; Ferreira L
Trends Biotechnol; 2016 May; 34(5):382-393. PubMed ID: 26838094
[TBL] [Abstract][Full Text] [Related]
35. Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems.
Liu H; Dong K; Zhang W; Summerfield SG; Terstappen GC
Drug Discov Today; 2018 Jul; 23(7):1357-1372. PubMed ID: 29548981
[TBL] [Abstract][Full Text] [Related]
36. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
de Lange EC
Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
[TBL] [Abstract][Full Text] [Related]
37. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
38. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
Tachikawa M; Uchida Y; Terasaki T
Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
[TBL] [Abstract][Full Text] [Related]
39. [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
Jacob A; Declèves X; Scherrmann JM
Biol Aujourdhui; 2012; 206(3):177-83. PubMed ID: 23171840
[TBL] [Abstract][Full Text] [Related]
40. Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.
Sjöstedt N; Kortejärvi H; Kidron H; Vellonen KS; Urtti A; Yliperttula M
Pharm Res; 2014 Jan; 31(1):1-19. PubMed ID: 23797466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
